Core Needle Biopsy for Suspicious Gynecomastia
Core needle biopsy is recommended for suspicious gynecomastia to accurately distinguish between benign gynecomastia and male breast cancer, as it provides superior sensitivity, specificity, and correct histological grading compared to fine needle aspiration. 1
Diagnostic Evaluation Before Biopsy
Initial Assessment
- Most men with breast symptoms can be diagnosed based on clinical findings without imaging 1
- Gynecomastia presents as a soft, rubbery, or firm mobile mass directly under the nipple, often painful when present for less than 6 months 1
- Suspicious features warranting further evaluation include:
Imaging Recommendations
For men younger than 25 years with suspicious findings:
For men 25 years and older with suspicious findings:
Biopsy Technique Selection
Core Needle Biopsy vs. Fine Needle Aspiration
Core needle biopsy is superior to fine needle aspiration (FNA) for several reasons:
FNA has significant limitations:
Guidance Method Selection
Ultrasound guidance is preferred for core needle biopsy due to:
For lesions only visible on mammography, stereotactic-guided core biopsy is recommended 3, 1
For lesions only visible on DBT, DBT-guided core biopsy is recommended 3, 1
Post-Biopsy Considerations
- A post-biopsy marker clip should be placed to:
- Confirm tissue sampling of the target lesion
- Aid in correlation when biopsy was performed with a different imaging modality than initial detection 1
- Post-biopsy imaging should be performed to document marker placement 1
Important Clinical Considerations
Male Breast Cancer Risk
- Male breast cancer is rare (accounting for <1% of all breast cancers) but should be ruled out, especially in older men (median age 63 years) 1
- Gynecomastia itself is not considered a premalignant condition 2
- Proper investigation may reveal an underlying pathology in 45-50% of adult gynecomastia cases 2
Diagnostic Pitfalls to Avoid
- Imaging should precede biopsy as post-biopsy changes may confuse image interpretation 3, 1
- Unnecessary imaging in clear cases of gynecomastia can lead to additional unnecessary benign biopsies 1
- Relying solely on clinical examination when suspicious features are present can miss malignancy 1
- Assuming that finding a cause for gynecomastia (such as medication use) eliminates the need for further evaluation when suspicious features are present 2
Laboratory Evaluation
- For suspicious cases, laboratory evaluation may include:
- Testosterone, estradiol, sex hormone-binding globulin
- Luteinizing hormone, follicle stimulating hormone
- Thyroid stimulating hormone, prolactin
- Human chorionic gonadotropin, alpha-fetoprotein
- Liver and renal function tests 2
By following this systematic approach to evaluation and biopsy of suspicious gynecomastia, clinicians can effectively distinguish between benign gynecomastia and male breast cancer, ensuring appropriate treatment and reducing unnecessary procedures.